Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Alamos Gold (AGI) offers a pragmatic long trade: a diversified three-mine producer, a market cap near $17.6 billion, and operational optionality that should benefit if gold stays firm. Multiples look distorted by current earnings and cash-flow swings, but valuation support from asset quality and a disciplined balance sheet make a mid-term long play…
Nvidia is moving past a pure semiconductor story toward an AI economics platform: GPUs remain the engine, but investments in cloud capacity deals, software stacks and guaranteed GPU take-or-pay arrangements are turning revenue into more predictable, higher-margin streams. The stock has pulled back into technical support and offers a risk-adjusted e…
Syngenta Group is preparing for a possible Hong Kong initial public offering that could raise as much as $10 billion this year, two people familiar with the discussions said, a move that would position the company among the largest IPOs in 2026. The Sinochem-owned agribusiness has been engaging multiple banks for potential roles on the transaction …
Meta is trading well below its 52-week high despite strong ad revenue acceleration and explicit AI-driven guidance. The company’s balance sheet, cash generation, and improving operating momentum create a favorable risk-reward for a mid-term long. Trade plan included with entry at $670, stop at $620, and target at $780 over 45 trading days.
AbbVie's recent pullback after the 02/04/2026 quarter is a buying opportunity for a mid-term trade. Strong growth in Skyrizi and Rinvoq offset Humira's decline and produced 10% reported sales growth in Q4 2025; the market sold the stock on concerns about Humira erosion and aesthetics. Valuation is full but not frothy for a cash-generative pharma wi…
Symbotic reported a revenue beat in Q1 and raised guidance; with a reported multi-billion backlog and major retail customers racing to automate, the stock offers a mid-term long trade. Valuation looks rich on headline market cap but free cash flow and backlog conversion argue for upside if execution continues. Enter at $61.00, stop $50.00, target $…
India and the United States expect to finalize a formal trade agreement in March, Trade Minister Piyush Goyal said, with a joint statement due in four to five days. The pact will see New Delhi cut tariffs on U.S. goods and prompt Washington to lower duties on Indian exports from 50% to 18%. India plans to import at least $500 billion of U.S. goods …
China said it regretted the lapse of the New START treaty and urged the United States to re-engage Russia on strategic stability. Beijing reiterated its self-defence nuclear stance, no-first-use commitment, and refusal to join bilateral arms-reduction negotiations, while noting its arsenal is smaller than those of Washington and Moscow.
MIELY looks positioned to outpace consensus in its next quarterly report thanks to strength in power systems, factory automation, and electronic devices. The stock shows bullish technicals and has run up from a $29.94 52-week low to a $69.85 high, but valuation still looks reasonable versus the recovery in profitability. This is a tactical long wit…
Indonesian equities ended the session lower, with the IDX Composite falling 0.23% as losses concentrated in the Infrastructure, Agriculture and Basic Industry sectors. Market breadth favored decliners, while several individual stocks posted large intraday gains or losses. Commodity and currency moves included declines in crude and Brent oil and mod…
The French Navy intercepted a vessel in the Caribbean carrying roughly 678 kilogrammes of cocaine and transferred custody to Barbadian authorities, France's Armed Forces Minister said. The seizure comes as France intensifies actions against drug trafficking linked to rising gang-related crime at home and an observed increase in cocaine use, prompti…
Rapid strides in AI, highlighted by recent product pushes from Anthropic and Palantir, have prompted analysts to warn that automation could structurally reduce high-margin application services revenue across the IT sector. Indian software exporters experienced share declines amid fears of shorter project timelines and a challenge to the labour-inte…
Pakistan's armed forces announced the conclusion of a week-long security campaign in Balochistan that they say killed 216 militants. The operation followed coordinated strikes by the Baloch Liberation Army that brought large parts of the province to a standstill, resulting in deaths among security personnel and civilians and the temporary seizure o…
A surge of foreign capital into Malaysian assets reflects growing investor confidence in the country’s steady growth, policy stability and a strengthening ringgit. Foreign inflows into local-currency debt, a rising stock market, and substantial data centre investment have positioned Malaysia as an attractive middle ground for global investors seeki…
Thousands of students across Serbia have rallied over the past year following the collapse of a railway station roof that killed 16 people, demanding government accountability. For students from the Bosniak Muslim-majority Sandzak region, the protests have offered an unexpected sense of inclusion. A long march from Novi Pazar to Novi Sad, where dem…
Kathryn L. Schoenrock, Executive Vice President and Chief Information Officer of Graco Inc (NYSE: GGG), sold 2,223 shares on February 2, 2026, for $195,759 and exercised options for 3,336 shares the same day. Graco reported fourth-quarter 2025 EPS of $0.77 and revenue of $593.2 million, slightly above expectations, with management citing acquisitio…
Graco Inc. director J. Kevin Gilligan carried out a same-day option exercise and share sale on February 3, 2026. Gilligan exercised options to acquire 12,870 shares, then sold those 12,870 shares at a weighted average price of $89.0676, generating roughly $1.15 million in proceeds. After the transactions he holds no shares directly but retains an i…
Associated Banc-Corp (ASB) offers a pragmatic trade setup: inexpensive valuation (P/B ~0.98), a solid yield (~3.3%), a freshly authorized $100M repurchase program and bullish technical momentum near the 52-week high. The combination supports a mid-term swing trade with asymmetric reward-to-risk if you keep stops tight and respect CRE/liquidity risk…
Vend Marketplaces ASA finished 2025 with a strong fourth quarter, reporting EBITDA that exceeded the company-compiled consensus by 13.6%. Group revenues were in line with expectations while verticals delivered revenue and adjusted EBITDA beats. Management provided qualitative guidance for 2026 and flagged execution issues around a platform migratio…
Allogene Therapeutics Executive Vice President of Research and Development Zachary Roberts sold 35,700 shares on Feb. 2, 2026 for roughly $63,189, according to a Form 4 filing. The transaction occurred at prices between $1.71 and $1.87, close to the stock's cited trading level of $1.80. Roberts also received option awards and restricted stock units…
RENK Group (RNKGF) has seen a sharp pullback into oversold territory alongside surging short interest and very low trading volumes. For traders willing to accept OTC liquidity risk, a defined-entry long with a clear stop and a mid-term target provides an asymmetric risk/reward to capture a rebound tied to defense spending tailwinds and a likely tec…
Jay D. Richards, an officer of a BankUnited subsidiary, sold 3,506 shares on February 3, 2026, for $49.83 per share, a transaction worth $174,703 executed under Rule 144. The sale leaves Richards with 35,687 shares. The move comes while BankUnited (BKU) trades near its 52-week high and follows a quarter that prompted multiple upward adjustments to …
Maersk reported fourth-quarter underlying EBITDA broadly in line with analyst forecasts and issued guidance for substantially lower underlying EBITDA in 2026, citing falling freight rates and ongoing industry challenges as headwinds for the coming year. Management highlighted continued transformation in global trade flows and supply chains as the c…
John W. Kozarich, a director at Ligand Pharmaceuticals, sold 467 shares of the company on February 2, 2026, in transactions totaling $91,490. The trades were made under a pre-established Rule 10b5-1 plan adopted March 7, 2025. Ligand recently reported robust third-quarter revenue of $115.5 million, driven in part by $53.1 million from the Pelthos t…
Allogene Therapeutics President and CEO Chang David D. sold 95,269 shares on February 2, 2026 to meet tax withholding tied to vested restricted stock units, a transaction that generated $171,484. The move occurred against a backdrop of strong recent share performance, a favorable arbitration ruling on the company’s cell therapy, an earnings beat fo…
